The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leukemia, Hairy Cell

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukemia, Hairy Cell


High impact information on Leukemia, Hairy Cell


Chemical compound and disease context of Leukemia, Hairy Cell


Biological context of Leukemia, Hairy Cell


Anatomical context of Leukemia, Hairy Cell


Gene context of Leukemia, Hairy Cell


Analytical, diagnostic and therapeutic context of Leukemia, Hairy Cell


  1. Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders. Heslop, H.E., Bianchi, A.C., Cordingley, F.T., Turner, M., Chandima, W., De Mel, C.P., Hoffbrand, A.V., Brenner, M.K. J. Exp. Med. (1990) [Pubmed]
  2. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia. Shehata, M., Schwarzmeier, J.D., Hilgarth, M., Hubmann, R., Duechler, M., Gisslinger, H. J. Clin. Invest. (2004) [Pubmed]
  3. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Wheaton, S., Tallman, M.S., Hakimian, D., Peterson, L. Blood (1996) [Pubmed]
  4. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Hanson, C.A., Gribbin, T.E., Schnitzer, B., Schlegelmilch, J.A., Mitchell, B.S., Stoolman, L.M. Blood (1990) [Pubmed]
  5. Detection of two distinct malignant B cell clones in a single patient using anti-idiotype monoclonal antibodies and immunoglobulin gene rearrangement. Giardina, S.L., Schroff, R.W., Woodhouse, C.S., Golde, D.W., Oldham, R.K., Cleary, M.L., Sklar, J., Pritikin, N., Foon, K.A. Blood (1985) [Pubmed]
  6. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. Kreitman, R.J., Wilson, W.H., Bergeron, K., Raggio, M., Stetler-Stevenson, M., FitzGerald, D.J., Pastan, I. N. Engl. J. Med. (2001) [Pubmed]
  7. More on the association of glucose-6-phosphate dehydrogenase deficiency with hairy-cell leukemia. Beutler, E., Kuhl, W., Gilsanz, F., Toscano, R.M. N. Engl. J. Med. (1991) [Pubmed]
  8. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. Piro, L.D., Carrera, C.J., Carson, D.A., Beutler, E. N. Engl. J. Med. (1990) [Pubmed]
  9. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin). Spiers, A.S., Moore, D., Cassileth, P.A., Harrington, D.P., Cummings, F.J., Neiman, R.S., Bennett, J.M., O'Connell, M.J. N. Engl. J. Med. (1987) [Pubmed]
  10. Lithium in hairy-cell leukemia. Blum, S.F. N. Engl. J. Med. (1980) [Pubmed]
  11. Newer purine analogues for the treatment of hairy-cell leukemia. Saven, A., Piro, L. N. Engl. J. Med. (1994) [Pubmed]
  12. Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retroviruses. Sohn, C.C., Blayney, D.W., Misset, J.L., Mathé, G., Flandrin, G., Moran, E.M., Jensen, F.C., Winberg, C.D., Rappaport, H. Blood (1986) [Pubmed]
  13. Treatment of hairy cell leukemia (leukemic reticuloendotheliosis) II. Chlorambucil therapy in postsplenectomy patients with progressive disease. Golomb, H.M., Mintz, U. Blood (1979) [Pubmed]
  14. Increased cholesterol biosynthesis in leukemic cells from patients with hairy cell leukemia. Yachnin, S., Golomb, H.M., West, E.J., Saffold, C. Blood (1983) [Pubmed]
  15. The effectiveness of rubidazone in hairy cell leukemia (leukemic reticuloendotheliosis). Stewart, D.J., Benjamin, R.S., McCredie, K.B., Murphy, S., Keating, M. Blood (1979) [Pubmed]
  16. Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells. Billard, C., Sigaux, F., Castaigne, S., Valensi, F., Flandrin, G., Degos, L., Falcoff, E., Aguet, M. Blood (1986) [Pubmed]
  17. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M.A., Villamor, N., Tassies, D., Jaffe, E.S., Montserrat, E., Rozman, C. Blood (1994) [Pubmed]
  18. Hairy cell interactions with extracellular matrix: expression of specific integrin receptors and their role in the cell's response to specific adhesive proteins. Burthem, J., Baker, P.K., Hunt, J.A., Cawley, J.C. Blood (1994) [Pubmed]
  19. Phosphorylation of CD20 in cells from a hairy cell leukemia cell line. Evidence for involvement of calcium/calmodulin-dependent protein kinase II. Genot, E.M., Meier, K.E., Licciardi, K.A., Ahn, N.G., Uittenbogaart, C.H., Wietzerbin, J., Clark, E.A., Valentine, M.A. J. Immunol. (1993) [Pubmed]
  20. Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia. Kane, B.J., Kuhn, J.G., Roush, M.K. The Annals of pharmacotherapy. (1992) [Pubmed]
  21. Establishment of a hairy cell leukemia cell line carrying Tac antigen and phagocytic activity with B-cell characteristics. Matsuo, Y., Sagawa, K., Morita, M., Minowada, J., Yokoyama, M.M. J. Natl. Cancer Inst. (1986) [Pubmed]
  22. Immunologic abnormalities in patients with malignant lymphoproliferative diseases. Hunter, C.P., Tannenbaum, H., Churchill, W.H., Moloney, W.C., Schur, P.H. J. Natl. Cancer Inst. (1977) [Pubmed]
  23. Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity. Jansen, J.H., van der Harst, D., Wientjens, G.J., Kooy-Winkelaar, Y.M., Brand, A., Willemze, R., Kluin-Nelemans, H.C. Blood (1992) [Pubmed]
  24. Hairy cell leukemia-associated antigen LeuM5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 T cells. Chadburn, A., Inghirami, G., Knowles, D.M. Am. J. Pathol. (1990) [Pubmed]
  25. 2-Chlorodeoxyadenosine therapy for idiopathic hypereosinophilic syndrome. Ueno, N.T., Zhao, S., Robertson, L.E., Consoli, U., Andreeff, M. Leukemia (1997) [Pubmed]
  26. Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion. Baker, P.K., Pettitt, A.R., Slupsky, J.R., Chen, H.J., Glenn, M.A., Zuzel, M., Cawley, J.C. Blood (2002) [Pubmed]
  27. Phenotypic analysis of hairy cell leukemia: "variant" cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25). de Totero, D., Tazzari, P.L., Lauria, F., Raspadori, D., di Celle, P.F., Carbone, A., Gobbi, M., Foa, R. Blood (1993) [Pubmed]
  28. Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia. Kamiguti, A.S., Serrander, L., Lin, K., Harris, R.J., Cawley, J.C., Allsup, D.J., Slupsky, J.R., Krause, K.H., Zuzel, M. J. Immunol. (2005) [Pubmed]
  29. Cyclin D1 protein expression in mantle cell lymphoma. Alkan, S., Schnitzer, B., Thompson, J.L., Moscinski, L.C., Ross, C.W. Ann. Oncol. (1995) [Pubmed]
  30. Expression of the IL2 receptor alpha, beta and gamma chains in hairy cell leukemia. de Totero, D., Carbone, A., Tazzari, P.L., Raspadori, D., Ventura, A., Reato, G., Lauria, F., Foa, R. Leuk. Lymphoma (1994) [Pubmed]
  31. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group. Johnston, J.B., Eisenhauer, E., Corbett, W.E., Scott, J.G., Zaentz, S.D. J. Natl. Cancer Inst. (1988) [Pubmed]
  32. Chlorambucil therapy in hairy cell leukemia: effects on lipid composition and lymphocyte subpopulations. Krigel, R., Liebes, L.F., Pelle, E., Silber, R. Blood (1982) [Pubmed]
  33. Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia. Hakimian, D., Tallman, M.S., Hogan, D.K., Rademaker, A.W., Rose, E., Nemcek, A.A. J. Clin. Oncol. (1994) [Pubmed]
  34. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. Juliusson, G., Heldal, D., Hippe, E., Hedenus, M., Malm, C., Wallman, K., Stolt, C.M., Evensen, S.A., Albertioni, F., Tjønnfjord, G. J. Clin. Oncol. (1995) [Pubmed]
  35. Action of interferons in hairy cell leukemia. Samuels, B.L., Rosner, M.C., Giometti, C.S., Golomb, H.M., Brownstein, B.H. Leukemia (1987) [Pubmed]
WikiGenes - Universities